Drug Patents owned by Schering

1. List of Noxafil drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8263600 SCHERING Antifungal composition with enhanced bioavailability
Apr, 2022

(1 year, 1 day ago)

Drugs and Companies using POSACONAZOLE ingredient

Market Authorisation Date: 15 September, 2006

Treatment: NA

Dosage: SUSPENSION;ORAL

How can I launch a generic of NOXAFIL before it's patent expiration?
More Information on Dosage

NOXAFIL family patents

4

United States

2

Japan

2

Australia

2

European Union

1

Argentina

1

Brazil

1

Hungary

1

South Africa

1

New Zealand

1

Canada

1

Mexico

1

Peru

1

Norway

1

Poland

1

Korea, Republic of

1

Taiwan, Province of China

1

China

2. List of Rebetol drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6790837 SCHERING Ribavirin syrup formulations
Apr, 2023

(2 days from now)

US6790837

(Pediatric)

SCHERING Ribavirin syrup formulations
Oct, 2023

(6 months from now)

Drugs and Companies using RIBAVIRIN ingredient

Market Authorisation Date: 29 July, 2003

Treatment: NA

Dosage: SOLUTION;ORAL

More Information on Dosage

REBETOL family patents

3

United States

1

South Africa

1

Denmark

1

Austria

1

Mexico

1

Australia

1

Hong Kong

1

Slovenia

1

Hungary

1

Norway

1

Germany

1

Argentina

1

Colombia

1

Brazil

1

Portugal

1

Cyprus

1

Spain

1

Korea, Republic of

1

Peru

1

Poland

1

Taiwan, Province of China

1

China

1

Japan

1

Canada

1

New Zealand

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic